INVO Fertility Debt to Equity Ratio 2012-2025 | IVF
Current and historical debt to equity ratio values for INVO Fertility (IVF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. INVO Fertility debt/equity for the three months ending September 30, 2025 was 0.00.
| INVO Fertility Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.01B | $0.01B | 2.22 |
| 2025-06-30 | $0.02B | $0.00B | 6.34 |
| 2025-03-31 | $0.02B | $0.01B | 3.34 |
| 2024-12-31 | $0.03B | $0.02B | 1.30 |
| 2024-09-30 | $0.02B | $0.00B | -731.45 |
| 2024-06-30 | $0.02B | $0.00B | 12.02 |
| 2024-03-31 | $0.02B | $0.00B | 1794.86 |
| 2023-12-31 | $0.02B | $0.00B | 19.73 |
| 2023-09-30 | $0.02B | $0.00B | 51.24 |
| 2023-06-30 | $0.01B | $0.00B | -4.89 |
| 2023-03-31 | $0.01B | $0.00B | 68.51 |
| 2022-12-31 | $0.01B | $0.00B | -4.80 |
| 2022-09-30 | $0.00B | $0.00B | 2.63 |
| 2022-06-30 | $0.00B | $0.00B | 0.91 |
| 2022-03-31 | $0.00B | $0.01B | 0.52 |
| 2021-12-31 | $0.00B | $0.01B | 0.43 |
| 2021-09-30 | $0.01B | $0.00B | 2.46 |
| 2021-06-30 | $0.01B | $0.00B | 1.28 |
| 2021-03-31 | $0.01B | $0.01B | 0.82 |
| 2020-12-31 | $0.01B | $0.01B | 0.91 |
| 2020-09-30 | $0.01B | $0.00B | -1.43 |
| 2020-06-30 | $0.01B | $0.00B | -1.64 |
| 2020-03-31 | $0.01B | $0.00B | -1.22 |
| 2019-12-31 | $0.01B | $0.00B | -1.48 |
| 2019-09-30 | $0.01B | $0.00B | -1.68 |
| 2019-06-30 | $0.01B | $0.00B | -2.08 |
| 2019-03-31 | $0.01B | $0.00B | -2.13 |
| 2018-12-31 | $0.00B | $0.00B | -1.29 |
| 2018-09-30 | $0.01B | $0.00B | -1.21 |
| 2018-06-30 | $0.01B | $0.00B | -1.28 |
| 2018-03-31 | $0.01B | $-0.01B | -1.06 |
| 2017-12-31 | $0.01B | $-0.01B | -1.05 |
| 2017-09-30 | $0.01B | $-0.01B | -1.04 |
| 2017-06-30 | $0.01B | $-0.01B | -1.04 |
| 2017-03-31 | $0.01B | $-0.01B | -1.04 |
| 2016-12-31 | $0.01B | $-0.01B | -1.06 |
| 2016-09-30 | $0.01B | $0.00B | -1.09 |
| 2016-06-30 | $0.01B | $0.00B | -1.11 |
| 2016-03-31 | $0.00B | $0.00B | -1.14 |
| 2015-12-31 | $0.00B | $0.00B | -1.15 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | $0.00B | -1.04 |
| 2011-09-30 | $0.00B | $0.00B | -1.05 |
| 2011-06-30 | $0.00B | $0.00B | -1.05 |
| 2011-03-31 | $0.00B | $0.00B | -1.06 |
| 2010-12-31 | $0.00B | $0.00B | -1.07 |
| 2010-09-30 | $0.00B | $0.00B | -1.07 |
| 2010-06-30 | $0.00B | $0.00B | -1.08 |
| 2010-03-31 | $0.00B | $0.00B | -1.09 |
| 2009-12-31 | $0.00B | $0.00B | -1.09 |
| 2009-09-30 | $0.01B | $-0.01B | -1.10 |
| 2009-06-30 | $0.00B | $0.00B | -1.18 |
| 2009-03-31 | $0.00B | $0.00B | -1.28 |
| 2008-12-31 | $0.00B | $0.00B | -1.46 |
| 2008-09-30 | $0.00B | $0.00B | -1.51 |
| 2008-06-30 | $0.00B | $0.00B | 43.00 |
| 2008-03-31 | $0.00B | $0.00B | 0.97 |
| 2007-12-31 | $0.00B | $0.00B | -1.55 |
| 2007-09-30 | $0.00B | 0.00 | |
| 2007-06-30 | $0.00B | 0.00 | |
| 2007-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.076B | 30.86 |
| HCA Healthcare (HCA) | United States | $109.268B | 18.09 |
| CVS Health (CVS) | United States | $100.704B | 11.58 |
| Elevance Health (ELV) | United States | $82.860B | 12.15 |
| Cencora (COR) | United States | $67.884B | 21.88 |
| Natera (NTRA) | United States | $33.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $21.720B | 16.56 |
| Medpace Holdings (MEDP) | United States | $17.364B | 43.11 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.188B | 0.00 |
| Viatris (VTRS) | United States | $15.146B | 5.64 |
| ICON (ICLR) | Ireland | $14.921B | 14.81 |
| BioMerieux (BMXMF) | France | $14.304B | 0.00 |
| Solventum (SOLV) | United States | $13.884B | 13.48 |
| Revvity (RVTY) | United States | $12.644B | 23.28 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.650B | 20.51 |
| Avantor (AVTR) | United States | $8.441B | 12.90 |
| Sonic Healthcare (SKHHY) | Australia | $7.636B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.454B | 0.00 |
| HealthEquity (HQY) | United States | $7.313B | 27.35 |
| BrightSpring Health Services (BTSG) | United States | $6.935B | 41.34 |
| PACS (PACS) | United States | $6.185B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $6.135B | 40.28 |
| Sotera Health (SHC) | United States | $5.452B | 26.29 |
| Alignment Healthcare (ALHC) | United States | $4.351B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.022B | 53.08 |
| Concentras Parent (CON) | United States | $2.619B | 16.34 |
| Progyny (PGNY) | United States | $2.252B | 44.27 |
| Organon (OGN) | United States | $2.238B | 2.36 |
| Surgery Partners (SGRY) | United States | $1.993B | 25.68 |
| Establishment Labs Holdings (ESTA) | United States | $1.923B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.891B | 11.29 |
| Ardent Health (ARDT) | United States | $1.244B | 4.06 |
| Nutex Health (NUTX) | United States | $1.173B | 8.97 |
| Teladoc Health (TDOC) | United States | $1.173B | 0.00 |
| CareDx (CDNA) | United States | $1.045B | 17.08 |
| GoodRx Holdings (GDRX) | United States | $0.933B | 15.28 |
| Omada Health (OMDA) | United States | $0.898B | 0.00 |
| Embecta (EMBC) | United States | $0.755B | 4.29 |
| InnovAge Holding (INNV) | United States | $0.752B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.733B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.547B | 24.55 |
| CryoPort (CYRX) | United States | $0.545B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.481B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 8.40 |
| Agilon Health (AGL) | United States | $0.402B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.52 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.279B | 0.00 |
| So-Young (SY) | China | $0.272B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.255B | 53.65 |
| KindlyMD (NAKA) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| LifeMD (LFMD) | United States | $0.185B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |